We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
On this page the Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products
Information on medical facilities available in Timor-Leste.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for healthcare professionals, patients, and the public.
Collecting and acting on information on any adverse effects of electronic cigarette devices and refill containers on human health.
Guidance on moving medicines by air
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Apply now to join the AI Airlock pilot by the MHRA. Benefit from industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).